Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, announces that it has entered into a definitive agreement with CoreRx, Inc. (“CoreRx”) under which CoreRx will acquire Societal CDMO. CoreRx will commence a tender offer to acquire all outstanding shares of Societal CDMO for $1.10 per share in cash, subject to any applicable tax withholding. CoreRx, Inc. is an industry leading CDMO, providing innovative drug formulation, development, and GMP manufacturing to global pharmaceutical and biotech partners.
Read the full article: Societal CDMO Enters into Definitive Agreement to Be Acquired by CoreRx, Inc. //
Source: https://www.globenewswire.com/news-release/2024/02/28/2837478/30326/en/Societal-CDMO-Enters-Into-Definitive-Agreement-to-be-Acquired-by-CoreRx-Inc.html